Skip to content

24/7 dementia helpline 800-272-3900

Dementia Today

Phytopharm gives up after Parkinson’s drug failure

Dementia TodayPublished March 26, 20132 min read

Key points

  • British biotech Phytopharm gave up its search for a treatment for Parkinson’s Disease using a drug derived from subtropical plants on Tuesday and said it was looking to sell the business.
  • The company said it had held exploratory merger talks with a number of parties.
  • It abandoned research aiming to commercialize a drug for the management of obesity derived from a southern African cactus called Hoodia gordonii three years ago, to focus its efforts on Cogane instead.
  • The British company had hoped its compounds had the potential to be a new class of therapy for neurodegenerative diseases, such as Parkinson’s and motor neurone disease.

British biotech Phytopharm gave up its search for a treatment for Parkinson’s Disease using a drug derived from subtropical plants on Tuesday and said it was looking to sell the business.

A month after the medicine, Cogane, failed in a clinical trial, Phytopharm said it would not commit any more money to further research and development and would cut staff.

The company said it had held exploratory merger talks with a number of parties.

Cogane’s failure – the latest in a line that include Renovo, Minster and Antisoma – highlighted the all-or-nothing bet that small biotechs need to make to develop and launch drugs on their own.

Phytopharm suffered earlier setbacks. It abandoned research aiming to commercialize a drug for the management of obesity derived from a southern African cactus called Hoodia gordonii three years ago, to focus its efforts on Cogane instead.

It raised 24 million pounds ($36 million)from investors to fund research into Cogane.

The British company had hoped its compounds had the potential to be a new class of therapy for neurodegenerative diseases, such as Parkinson’s and motor neurone disease.

Early trials indicated that Cogane could ease the symptoms and slow the progression of Parkinson’s, a condition where part of the brain becomes more damaged over time.

However, the drug, derived from a member of the sapogenin class of compounds, last month failed to show any benefit over a placebo in a trial of 400 patients with early-stage Parkinson’s.

The company said on Tuesday that a full analysis of the data confirmed the disappointing findings.

Shares in the group, which fell more than 80 percent when the trial results were published, were trading up 3 percent at 1.56 pence by 1016 GMT, valuing the company at about 5.4 million pounds ($8.2 million).

###

(Reuters)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If a person with dementia is missing, injured or in danger, call 911 or your local emergency number.

Filed underDementia News

Worried about memory changes?

Normal aging, or an early warning sign?

Ten common changes, each set beside what is typical with age. Tick what you have noticed and see what to do next.

Open the 10-sign checklist

Getting help

Sudden changes are not just the dementia.

Dementia usually changes slowly. A sharp change over hours or days can mean an infection, delirium, a stroke or a medication problem, and needs a doctor the same day. Call 911 or your local emergency number if you see any of these:

  • Confusion that comes on suddenly, over hours or days
  • Face drooping, arm weakness or slurred speech
  • A fall, a head injury or new severe pain
  • Very drowsy or hard to wake

The free Alzheimer’s Association Helpline answers questions about memory loss, diagnosis and caregiving, day and night, in more than 200 languages (US).

If someone with dementia is missing

  1. STEP 115 minSearch close by firstCheck the house, garden, car and the places the person often walks to. Don’t spend longer than about 15 minutes.
  2. STEP 2911Then call for helpTell the operator the person has dementia and is a vulnerable adult. Police treat this as urgent.
  3. STEP 3PhotoHave details readyA recent photo, what they were wearing, medical conditions and places they used to live or work.

Based on Alzheimer’s Association guidance on wandering. Outside the US, call your local emergency number.